Birk Möller,Lena-Luise Becker,Afshin Saffari,Alexandra Afenjar,Emanuele G Coci,Rachel Williamson,Catherine Ward-Melver,Marc Gibaud,Lucie Sedláčková,Petra Laššuthová,Zuzana Libá,Markéta Vlčková,Nancy William,Eric W Klee,Ralitza H Gavrilova,Jonathan Lévy,Yline Capri,Mena Scavina,Robert Walter Körner,Zaheer Valuvullah,Claudia Weiß,Greta Marit Möller,Moritz Thiel,Margje Sinnema,Erik-Jan Kamsteeg,Sandra Donkervoort,Veronique Duboc,Khaoula Zaafrane-Khachnaoui,Nour Elkhateeb,Laila Selim,Henri Margot,Victor Marin,Claire Beneteau,Bertrand Isidor,Benjamin Cogne,Boris Keren,Benno Küsters,Alan H Beggs,Casie A Genetti,Joost Nicolai,Jörg Dötsch,Anne Koy,Carsten G Bönnemann,Maja von der Hagen,Jürgen-Christoph von Kleist-Retzow,Nicol Voermans,Heinz Jungbluth,Hormos Salimi Dafsari

Abstract:Intracellular trafficking involves an intricate machinery of motor complexes including the dynein complex to shuttle cargo for autophagolysosomal degradation. Deficiency in dynein axonemal chains as well as cytoplasmic light and intermediate chains have been linked with ciliary dyskinesia and skeletal dysplasia. The cytoplasmic dynein 1 heavy chain protein (DYNC1H1) serves as a core complex for retrograde trafficking in neuronal axons. Dominant pathogenic variants in DYNC1H1 have been previously implicated in peripheral neuromuscular disorders (NMD) and neurodevelopmental disorders (NDD). As heavy-chain dynein is ubiquitously expressed, the apparent selectivity of heavy-chain dyneinopathy for motor neuronal phenotypes remains currently unaccounted for. Here, we aimed to evaluate the full DYNC1H1 -related clinical, molecular and imaging spectrum, including multisystem features and novel phenotypes presenting throughout life. We identified 47 cases from 43 families with pathogenic heterozygous variants in DYNC1H1 (aged 0-59 years) and collected phenotypic data via a comprehensive standardized survey and clinical follow-up appointments. Most patients presented with divergent and previously unrecognized neurological and multisystem features, leading to significant delays in genetic testing and establishing the correct diagnosis. Neurological phenotypes include novel autonomic features, previously rarely described behavioral disorders, movement disorders, and periventricular lesions. Sensory neuropathy was identified in nine patients (median age of onset 10.6 years), of which five were only diagnosed after the second decade of life, and three had a progressive age-dependent sensory neuropathy. Novel multisystem features included primary immunodeficiency, bilateral sensorineural hearing loss, organ anomalies, and skeletal manifestations, resembling the phenotypic spectrum of other dyneinopathies. We also identified an age-dependent biphasic disease course with developmental regression in the first decade and, following a period of stability, neurodegenerative progression after the second decade of life. Of note, we observed several cases in whom neurodegeneration appeared to be prompted by intercurrent systemic infections with double-stranded DNA viruses (Herpesviridae) or single-stranded RNA viruses (Ross-River fever, SARS-CoV-2). Moreover, the disease course appeared to be exacerbated by viral infections regardless of age and/or severity of NDD manifestations, indicating a role of dynein in anti-viral immunity and neuronal health. In summary, our findings expand the clinical, imaging, and molecular spectrum of pathogenic DYNC1H1 variants beyond motor neuropathy disorders and suggest a life-long continuum and age-related progression due to deficient intracellular trafficking. This study will facilitate early diagnosis and improve counselling and health surveillance of affected patients.

Patient-specific mutation of Dync1h1 in mice causes brain and behavioral deficits

Exome Sequencing Identifies De Novo DYNC1H1 Mutations Associated with Distal Spinal Muscular Atrophy and Malformations of Cortical Development

Behavioral and Electrophysiological Characterization of Dyt1 Heterozygous Knockout Mice

Missense mutation in DYNC1H1 gene caused psychomotor developmental delay and muscle weakness: A case report

Case report: Genotype and phenotype of <i>DYNC1H1</i>-related malformations of cortical development: a case report and literature review

Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice

Mice Carrying an Analogous Heterozygous Dynamin 2 K562E Mutation That Causes Neuropathy in Humans Develop Predominant Characteristics of a Primary Myopathy

A conditional null allele of Dync1h1 enables targeted analyses of dynein roles in neuronal length sensing

Expanding the Phenotypic and Genetic Spectrum of Neuromuscular Diseases Caused by DYNC1H1 Mutations

Dlic1 Deletion Impaired Cerebellar Development in Mouse

Dync1h1 Mutation Causes Proprioceptive Sensory Neuron Loss and Impaired Retrograde Axonal Transport of Dorsal Root Ganglion Neurons

Face-valid phenotypes in a mouse model of the most common mutation in EEF1A2 -related neurodevelopmental disorder

The expanding clinical and genetic spectrum of DYNC1H1 -related disorders

Mutation in ZDHHC15 Leads to Hypotonic Cerebral Palsy, Autism, Epilepsy, and Intellectual Disability

Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathy

Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia

Human mutations in NDE1 cause extreme microcephaly with lissencephaly [corrected]

CDKL5's role in microtubule-based transport and cognitive function

Nacc1 mutation in mice models rare neurodevelopmental disorder with underlying synaptic dysfunction

Dynamin 1 isoform roles in a mouse model of severe childhood epileptic encephalopathy

DNMT1 Y495C mutation interferes with maintenance methylation of imprinting control regions